Cargando…

Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis

Current understanding of Multiple Sclerosis (MS) pathophysiology implicates perturbations in adaptive cellular immune responses, predominantly T cells, in Relapsing-Remitting forms (RRMS). Nevertheless, from a clinical perspective MS is a heterogeneous disease reflecting the heterogeneity of involve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vakrakou, Aigli G., Paschalidis, Nikolaos, Pavlos, Eleftherios, Giannouli, Christina, Karathanasis, Dimitris, Tsipota, Xristina, Velonakis, Georgios, Stadelmann-Nessler, Christine, Evangelopoulos, Maria-Eleftheria, Stefanis, Leonidas, Kilidireas, Constantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905713/ https://www.ncbi.nlm.nih.gov/pubmed/36761741 http://dx.doi.org/10.3389/fimmu.2023.1071623

Ejemplares similares

Alemtuzumab-induced alopecia universalis and transient accommodation spasm in a patient with multiple sclerosis
por: Tzanetakos, Dimitrios, et al.
Publicado: (2022)

Moyamoya Disease May Mimic Multiple Sclerosis?
por: Spanou, Ioanna, et al.
Publicado: (2019)

Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study
por: Kazakou, Paraskevi, et al.
Publicado: (2023)

Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases
por: Vakrakou, Aigli G., et al.
Publicado: (2021)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature
por: Vakrakou, Aigli G., et al.
Publicado: (2020)

An Updated Evaluation of Intrathecal IgG Synthesis Markers in Relation to Oligoclonal Bands
por: Boufidou, Fotini, et al.
Publicado: (2023)

Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients
por: Kazakou, Paraskevi, et al.
Publicado: (2021)

Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts
por: Tzanetakos, D., et al.
Publicado: (2020)

The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity
por: Karathanasis, Dimitris K., et al.
Publicado: (2022)

Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review
por: Yiannopoulou, Konstantina, et al.
Publicado: (2023)

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course
por: Zoehner, Greta, et al.
Publicado: (2019)

A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes
por: Vakrakou, A. G., et al.
Publicado: (2018)

Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study
por: Miclea, Andrei, et al.
Publicado: (2018)

Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion
por: Tzartos, John S., et al.
Publicado: (2020)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

Body Mass Index in Multiple Sclerosis: Associations with CSF Neurotransmitter Metabolite Levels
por: Markianos, Manolis, et al.
Publicado: (2013)

Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient’s COVID-19 Infection
por: Markoglou, Nikolaos, et al.
Publicado: (2022)

Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
por: Koros, Christos, et al.
Publicado: (2013)

Immune Reconstitution Inflammatory Syndrome Mimicking Progressive Multifocal Leucoencephalopathy in a Multiple Sclerosis Patient Treated With Natalizumab: A Case Report and Review of the Literature
por: Evangelopoulos, Maria-Eleptheria, et al.
Publicado: (2015)

Perturbation of transcriptome in non-neoplastic salivary gland epithelial cell lines derived from patients with primary Sjögren's syndrome
por: Vakrakou, Aigli G., et al.
Publicado: (2017)

Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases
por: Kapaki, Elisabeth, et al.
Publicado: (2022)

The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015)

Serum Leptin Levels in Treatment-Naive Patients with Clinically Isolated Syndrome or Relapsing-Remitting Multiple Sclerosis
por: Evangelopoulos, Maria Eleftheria, et al.
Publicado: (2014)

The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement
por: Raftopoulou, Sylvia, et al.
Publicado: (2022)

Imaging Markers for Normal Pressure Hydrocephalus: An Overview
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2023)

The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials
por: Tsivgoulis, Georgios, et al.
Publicado: (2016)

Increased plasma homocysteine levels in patients with multiple sclerosis and depression
por: Triantafyllou, Nikolaos, et al.
Publicado: (2008)

The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015)

Callosal Angle Sub-Score of the Radscale in Patients with Idiopathic Normal Pressure Hydrocephalus Is Associated with Positive Tap Test Response
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2022)

Early metabolic alterations in the normal‑appearing grey and white matter of patients with clinically isolated syndrome suggestive of multiple sclerosis: A proton MR spectroscopic study
por: Tzanetakos, Dimitrios, et al.
Publicado: (2023)

Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity
por: Fish, Simon, et al.
Publicado: (2021)

Rituximab as Rescue Therapy for Aggressive Pediatric Multiple Sclerosis
por: Vartzelis, George, et al.
Publicado: (2019)

Impaired Clearance of Early Apoptotic Cells Mediated by Inhibitory IgG Antibodies in Patients with Primary Sjögren's Syndrome
por: Manoussakis, Menelaos N., et al.
Publicado: (2014)

P701: SYSTEMATIC ANALYSIS OF T LYMPHOCYTES IN MYELOID NEOPLASMS
por: Tasis, Athanasios, et al.
Publicado: (2023)

A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson’s disease and multiple sclerosis
por: Eschweiler, Mareike, et al.
Publicado: (2023)

The Clinical and Radiological Spectrum of Hippocampal Pathology in Amyotrophic Lateral Sclerosis
por: Christidi, Foteini, et al.
Publicado: (2018)

Adenosquamous carcinoma of the pancreas, a rare tumor entity: a case report
por: Lampropoulos, Pavlos, et al.
Publicado: (2009)

Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece
por: Dardiotis, Efthymios, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s28is3lm1mi2m121hfprja3hlh